COVID-19 : Neutralizing Human Monoclonal Antibodies Against SARS-Cov-2

计划入组 10 人 · 首次发布于 2020 年 4 月 21 日

A Study of Human Monoclonal Antibodies, BRII-196 and BRII-198

计划入组 48 人 · 首次发布于 2021 年 3 月 8 日

A Phase 1 Study of Human Monoclonal Antibodies, BRII-196 and BRII-198

计划入组 12 人 · 首次发布于 2020 年 12 月 31 日

human monoclonal antibodies (Covid-19)

anti-interferon-alpha human monoclonal antibodies

Human monoclonal antibodies against GM-CSF (Evec)

ImmunoPrecise Antibodies

Canada

OmniAb

United States

EicOsis Human Health, Inc.

United States

Fred Hutch Scientists Develop First Human Monoclonal Antibodies to Block Epstein-Barr Virus Infection

U.S. Monoclonal Antibodies Market Projected to Reach $284.9 Billion by 2034, Growing at 13.1% CAGR

SpikImm Secures Worldwide License for Anti-BK Virus Monoclonal Antibodies to Protect Transplant Patients